Literature DB >> 18567971

The potential role of a corticotropin-releasing factor receptor-1 antagonist in psychiatric disorders.

Stephen M Stahl1, Dana D Wise.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18567971     DOI: 10.1017/s1092852900016709

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


× No keyword cloud information.
  7 in total

Review 1.  Impaired emotional learning and involvement of the corticotropin-releasing factor signaling system in patients with irritable bowel syndrome.

Authors:  Jennifer S Labus; Catherine S Hubbard; Joshua Bueller; Bahar Ebrat; Kirsten Tillisch; Michelle Chen; Jean Stains; George E Dukes; Dennis L Kelleher; Bruce D Naliboff; Michael Fanselow; Emeran A Mayer
Journal:  Gastroenterology       Date:  2013-08-14       Impact factor: 22.682

Review 2.  Progress in corticotropin-releasing factor-1 antagonist development.

Authors:  Eric P Zorrilla; George F Koob
Journal:  Drug Discov Today       Date:  2010-03-03       Impact factor: 7.851

3.  Persistent anxiolytic affects after chronic administration of the CRF₁ receptor antagonist R121919 in rats.

Authors:  David A Gutman; Michael J Owens; K V Thrivikraman; Charles B Nemeroff
Journal:  Neuropharmacology       Date:  2010-10-14       Impact factor: 5.250

4.  Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse.

Authors:  Adrie W Bruijnzeel; Melissa Prado; Shani Isaac
Journal:  Biol Psychiatry       Date:  2009-02-12       Impact factor: 13.382

Review 5.  A role for corticotropin-releasing factor in functional gastrointestinal disorders.

Authors:  Yvette Taché; Cornelia Kiank; Andreas Stengel
Journal:  Curr Gastroenterol Rep       Date:  2009-08

Review 6.  Chronic functional bowel syndrome enhances gut-brain axis dysfunction, neuroinflammation, cognitive impairment, and vulnerability to dementia.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2014-03-04       Impact factor: 3.996

Review 7.  kappa-Opioid receptor signaling and brain reward function.

Authors:  Adrie W Bruijnzeel
Journal:  Brain Res Rev       Date:  2009-10-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.